Main Content

“2020health is an important and thoughtful contributor to the health debate”

Dr Sarah Wollaston MP, Chairman, Health Select Committee


The Optimum Health Clinic Foundation Press Release: Thursday 28th September 2017

Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (CFS/ME) costs the UK economy £3.3 billion a year

Today, the Optimum Health Clinic (OHC), a charity specialising in the research into CFS/ME, launches in conjunction with the think tank 2020health, ground-breaking research assessing the costs of CFS/ME to the UK economy. This study entitled “CFS/ME: counting the cost” is the first study to assess both the direct and indirect cost of this illness.
This illness costs the UK economy at least £3.3 billion each year.
David Butcher, chairman of the OHC said:
“For too long there has been too much argument about CFS/ME which has not translated into effective treatments for sufferers. The cost of this illness to our country shows that the time has come for a comprehensive research strategy into the bio medical causes of and effective treatments for this appalling illness. We commissioned this research into the cost of CFS/ME to the economy because we want to improve awareness of this poorly understood illness in order to argue for greater funding of research”.
Julia Manning, Founder Director of 2020health, the health think tank who carried out this research, said:
“2020health was very keen to undertake this research because we are acutely aware that there is a lack of understanding about CFS/ME in both the NHS and society, and that the economic implications of the condition were unknown. We are especially pleased to have shone a spotlight on the previously underestimated costs of CFS/ME to society, as this should provide a real incentive for more support and research into this illness”.
CFS/ME devastates the lives of sufferers, their families and their carers and destroyed lives deserve attention. “The only way we will put an end to the needless waste of lives and money is to develop a better understanding of this illness and finding more effective treatments, and the only way we will achieve that is by funding research into both bio medical causes and treatments”, said David Butcher.
David Butcher
07785 592751
Julia Manning
07973 312358